These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24736756)

  • 1. Acute coronary syndromes: Metformin not associated with improved left ventricular function after STEMI in patients without diabetes mellitus.
    Mearns BM
    Nat Rev Cardiol; 2014 Jun; 11(6):314. PubMed ID: 24736756
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
    Lexis CP; van der Horst IC; Lipsic E; Wieringa WG; de Boer RA; van den Heuvel AF; van der Werf HW; Schurer RA; Pundziute G; Tan ES; Nieuwland W; Willemsen HM; Dorhout B; Molmans BH; van der Horst-Schrivers AN; Wolffenbuttel BH; ter Horst GJ; van Rossum AC; Tijssen JG; Hillege HL; de Smet BJ; van der Harst P; van Veldhuisen DJ;
    JAMA; 2014 Apr; 311(15):1526-35. PubMed ID: 24687169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study answers long-standing question about metformin after heart attack.
    Caffrey MK
    Am J Manag Care; 2014 May; 20(8 Spec No.):E14. PubMed ID: 25617933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].
    Paneni F; Costantino S; Cosentino F
    G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
    Lexis CP; van der Horst IC; Lipsic E; van der Harst P; van der Horst-Schrivers AN; Wolffenbuttel BH; de Boer RA; van Rossum AC; van Veldhuisen DJ; de Smet BJ;
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):417-26. PubMed ID: 22968678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.
    Al Ali L; Hartman MT; Lexis CP; Hummel YM; Lipsic E; van Melle JP; van Veldhuisen DJ; Voors AA; van der Horst IC; van der Harst P
    PLoS One; 2016; 11(12):e0168340. PubMed ID: 27977774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.
    Eppinga RN; Kofink D; Dullaart RP; Dalmeijer GW; Lipsic E; van Veldhuisen DJ; van der Horst IC; Asselbergs FW; van der Harst P
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis.
    Basnet S; Kozikowski A; Makaryus AN; Pekmezaris R; Zeltser R; Akerman M; Lesser M; Wolf-Klein G
    J Am Heart Assoc; 2015 Oct; 4(10):e002314. PubMed ID: 26494519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial.
    Haver VG; Hartman MH; Mateo Leach I; Lipsic E; Lexis CP; van Veldhuisen DJ; van Gilst WH; van der Horst IC; van der Harst P
    Clin Res Cardiol; 2015 Oct; 104(10):812-21. PubMed ID: 25840550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction.
    Abualsuod A; Rutland JJ; Watts TE; Pandat S; Delongchamp R; Mehta JL
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):265-75. PubMed ID: 26068409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes.
    Andersson C; Søgaard P; Hoffmann S; Hansen PR; Vaag A; Major-Pedersen A; Hansen TF; Bech J; Køber L; Torp-Pedersen C; Gislason GH
    Eur J Endocrinol; 2010 Oct; 163(4):593-9. PubMed ID: 20679358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The time course of left ventricular remodeling after acute myocardial infarction.
    Glasser SP
    Am J Cardiol; 1997 Aug; 80(4):506-7. PubMed ID: 9285666
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction.
    Angeli FS; Amabile N; Burjonroppa S; Shapiro M; Bartlett L; Zhang Y; Virmani R; Chatterjee K; Boyle A; Grossman W; Yeghiazarians Y
    J Card Fail; 2010 Jul; 16(7):579-89. PubMed ID: 20610234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
    Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sex on the heart's metabolic and functional responses to diabetic therapies.
    Lyons MR; Peterson LR; McGill JB; Herrero P; Coggan AR; Saeed IM; Recklein C; Schechtman KB; Gropler RJ
    Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1584-91. PubMed ID: 24043256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure.
    Gundewar S; Calvert JW; Jha S; Toedt-Pingel I; Ji SY; Nunez D; Ramachandran A; Anaya-Cisneros M; Tian R; Lefer DJ
    Circ Res; 2009 Feb; 104(3):403-11. PubMed ID: 19096023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of New Antiplatelet Agents and Aldosterone Receptor Antagonists on Mortality in Patients with Myocardial Infarction.
    Eyuboglu M
    Cardiovasc Drugs Ther; 2015 Oct; 29(5):495. PubMed ID: 26233242
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Techiryan G; Weil BR; Palka BA; Canty JM
    Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease.
    Wilmanns JC; Pandey R; Hon O; Chandran A; Schilling JM; Forte E; Wu Q; Cagnone G; Bais P; Philip V; Coleman D; Kocalis H; Archer SK; Pearson JT; Ramialison M; Heineke J; Patel HH; Rosenthal NA; Furtado MB; Costa MW
    Mol Metab; 2019 Feb; 20():102-114. PubMed ID: 30482476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Letter to the Editor: Effects of New Antiplatelet Agents and Aldosterone Receptor Antagonists on Mortality in Patients with Myocardial Infarction.
    Abualsuod A
    Cardiovasc Drugs Ther; 2015 Oct; 29(5):497. PubMed ID: 26303764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.